Discogenic Back Pain

Discogenic back pain is internal disc disruption (IDD): a degenerative condition in which the nucleus pulposus loses its hydration and the annulus fibrosus develops painful fissures, without the frank herniation that compresses neural tissue. It is a mechanical and chemical pain syndrome arising from disrupted disc architecture, and it presents as axial low back pain from an annulus that is damaged but intact.

The key distinction. Discogenic pain is internal; a herniation is external compression.

View larger

How the pain arises. The nucleus loses proteoglycan, dehydrates, and the disc loses height. Annular tears propagate from the nucleus outward until they reach the pain-sensitive outer annular fibres, and inflammatory cytokines leak into the tears and sensitise nociceptors. The anatomy and chemistry behind this are in the next section.

The degenerative cascade. Four stages, each with the age band attached to it.

Natural history. Variable. Approximately 80% of patients improve with conservative care over 6-12 months, and the disc may burn out with progressive collapse and fibrosis, reducing pain. Younger patients with single-level disease and Modic Type 1 changes have a worse prognosis.

The disc. Three components.

Nucleus pulposus. A central gelatinous core, 80% water in youth, held by a proteoglycan matrix (aggrecan) that retains the water and given structure by type II collagen. It is aneural and avascular; its nutrients arrive by diffusion from the endplates.

Annulus fibrosus. Concentric lamellae of type I collagen, 15-25 layers with the fibre orientation alternating at 30 degrees between layers, anchored to the vertebral endplates by Sharpey fibres. Only the outer one-third is innervated.

Cartilaginous endplates. The interface between vertebral body and disc: the nutrient diffusion pathway for the avascular disc, and the surface that distributes load across the vertebral body. Endplate injury causes Modic changes and disc degeneration.

Innervation, the key to discogenic pain. The outer third of the annulus is supplied by:

• Sinuvertebral nerve (recurrent branch of the ventral ramus) - posterior and posterolateral annulus
• Grey rami communicantes - anterolateral annulus
• Dorsal rami - posterior annulus

The inner two-thirds is normally aneural. In discogenic pain, nerve growth factor (NGF) drives aberrant nerve ingrowth into the inner annulus along radial tears, creating pain-sensitive tissue in a zone that should have none.

The chemistry of the painful disc. Inflammatory cytokines (IL-1, IL-6, TNF-alpha and PGE2) leak into the fissures and sensitise nociceptors. Matrix metalloproteinases degrade collagen and proteoglycans, NGF drives the nerve ingrowth above, and substance P, a nociceptive neurotransmitter, is found in painful discs.

The mechanics of the failing disc. Annular incompetence distributes stress abnormally across the disc, and endplate fracture produces the Modic Type 1 change. The table sets the rest of the sequence against its clinical effect.

Load. In flexion, sitting raises intradiscal pressure by 200-300% compared with standing. That single figure explains why discogenic pain is characteristically worse with sitting and flexion activities.

Three systems describe three tissues. Pfirrmann grades the disc itself on T2 MRI, Modic describes the marrow response in the adjacent endplates, and the Dallas discogram grades the annular tear by how far contrast escapes the nucleus.

View larger

History. Axial, mechanical low back pain centred on the low back (L4-5 or L5-S1), worse with prolonged sitting, bending and lifting, and better standing, walking or lying supine. Sitting hurts because intradiscal pressure is highest there, and flexion because it increases annular stress. The pain may refer to the buttocks or posterior thighs but does not radiate below the knee and is not dermatomal, which is what rules out radiculopathy. Morning stiffness improves with movement. There is no nocturnal pain (unlike tumour) and there are no constitutional symptoms (unlike infection).

Examination. The neurological examination is normal and the straight leg raise negative, which distinguishes this from a herniation. Flexion is painful and range of motion is limited by pain; provocative testing makes discogenic pain worse in flexion. Facet loading (extension and rotation) is negative, which rules out a facet source.

A diagnosis of exclusion. Discogenic pain is confirmed only after the other sources have been ruled out:

• Facet arthropathy - pain worse with extension, positive facet loading tests
• Sacroiliac joint - provocative SI tests (FABER, Gaenslen)
• Myofascial pain - trigger points, muscle spasm
• Spondylolisthesis - palpable step-off, instability on dynamic radiographs
• Red flags - infection, tumour, fracture, cauda equina syndrome

Radiographs. Standing AP and lateral films assess disc height loss, alignment and instability, with flexion-extension views if instability is suspected. Their sensitivity for early discogenic pain is limited.

View larger

MRI is the gold standard. T1 and T2 sequences, read for disc morphology (the Pfirrmann grade), the high-intensity zone and Modic endplate changes. Sensitivity is 80-90% when combined with clinical correlation.

View larger

Diagnostic injections. Facet blocks or sacroiliac joint injections exclude the alternative pain sources. Over 50% pain relief from either suggests a non-discogenic source.

Discography - Controversial Gold Standard

The test. Intradiscal contrast injection under fluoroscopy with pressure monitoring: opening pressure and pain response are recorded at each level. A concordant result reproduces the patient's exact clinical pain at low pressure (under 15 psi above opening) at the affected level, with the control levels negative. It is called the gold standard, and the label is contested because of the potential for disc injury.

Indications are highly selective:

• Failed 6+ months of conservative care
• Single-level MRI abnormality with clinical correlation
• Fusion or disc replacement under consideration
• Multi-level degeneration in which the pain generator must be identified

The false-positive rate is not a fixed property of the test; it is a property of the patient. This is the single most important thing to know about discography, and it comes from Carragee's work. Injecting 26 people who had no back pain at all and following them for a year: not one subject with normal psychometric testing developed persistent pain (0 of 11), whereas 6 of 15 with abnormal psychometric testing (40%) reported significant new low back pain. Broken down by group: 0% of the pain-free group, 20% of those with chronic neck pain, and 66% of those with somatisation disorder.

The consequence for practice. A positive discogram in a psychologically well patient means something; a positive discogram in a distressed, disabled or somatising patient may mean nothing at all, and quoting a single "20-40% false-positive rate" hides exactly the variable that decides it.

It is not a harmless test. Beyond the immediate risks of discitis and bleeding, the same body of work links discography to accelerated degeneration of the injected disc, and in the study above the injection itself produced new, persistent back pain lasting at least a year in susceptible people. Inter-rater reliability is poor, and the pressure and volume thresholds that define a "positive" result are themselves contested.

The practical position. Many surgeons no longer perform it, and it should never be a screening test. If used at all, it is to answer a specific question in a psychologically screened patient in whom a decision hinges on the answer, and a positive result is a permissive finding, not an indication to operate.

Conservative Management - First Line

Conservative care is the mainstay, because of the natural history set out above. It is a structured, multimodal programme run for a minimum of 6 months before any intervention is considered.

Interventional and Surgical Management

Who is offered surgery. A highly selected patient with failed conservative care and a confirmed discogenic source. Because the outcomes are less predictable than those of decompression (see Outcomes), patient selection is critical.

Adjacent segment disease. The pre-existing degeneration that predicts it means MRI changes present at the index surgery. Many cases are asymptomatic radiographic degeneration; only 5-10% of patients need revision surgery. Disc replacement theoretically reduces it by preserving motion, but the long-term clinical benefit is unclear.

Fusion. 60-70% good to excellent outcomes at 2-5 years in well-selected patients. The results are less predictable than those of decompression for stenosis or herniation, and the predictors of a poor result are the contraindications listed under patient selection.

Disc replacement. 70-80% good to excellent outcomes at 5 years, similar to fusion. Adjacent segment disease is lower radiographically (15% vs 30%), but whether that is clinically significant is unclear. The failures are facet arthropathy, which develops in 10-15% and is itself a contraindication to the implant, and implant loosening or wear in the long term (over 10 years), which remains unknown.

Global Epidemiology

Low back pain is the single leading cause of years lived with disability worldwide; global disability from low back pain rose by 54% between 1990 and 2015, driven mainly by population growth and ageing, with the steepest rise in low- and middle-income countries (Hartvigsen, Lancet 2018). For the large majority of patients no specific nociceptive cause can be identified, and only a small minority have a clearly defined pathology such as fracture, malignancy or infection. Discogenic (internal disc disruption) pain is therefore a sub-diagnosis applied to a fraction of chronic axial low back pain, and degenerative MRI findings - including disc desiccation, anular tears, high-intensity zones and Modic changes - are common in entirely asymptomatic adults, rising in prevalence with age (Kjaer, Spine 2005). Physically demanding work, smoking, obesity, psychological distress and low socioeconomic status are the most consistent risk factors for reporting disabling low back pain.

Major Guidelines Side by Side

Registry and Device-Trial Evidence

• Arthroplasty IDE trials: The CHARITE and ProDisc-L FDA investigational device exemption RCTs underpin regulatory approval of lumbar total disc replacement, showing non-inferiority to fusion at 2 and 5 years with preserved segmental motion in selected single-level patients (Guyer, Spine J 2009).
• Spine registries (for example Sweden's Swespine, the British Spine Registry and several national arthroplasty/spine registries) collect patient-reported outcomes and revision data; they consistently show that outcomes of fusion for axial low back pain are less predictable than for decompression of radiculopathy or stenosis, and that careful patient selection drives results.

Practice Variation

Rates of lumbar fusion vary several-fold between and within countries for similar presentations, reflecting differences in reimbursement, surgeon preference, access to multidisciplinary rehabilitation and medicolegal climate rather than differences in disease. High-resource systems show rising arthroplasty and fusion volumes; lower-resource systems rely almost entirely on conservative care. This unexplained variation is itself an argument for adhering to guideline thresholds and shared decision-making.

Consent and Documentation (Globally Applicable)